Guidance
4 Other information
4.1 Scope and how this guideline was developed
NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover.
|
How this guideline was developed NICE commissioned the National Clinical Guideline Centre to develop this guideline. The Centre established a Guideline Development Group (see section 5), which reviewed the evidence and developed the recommendations. The methods and processes for developing NICE clinical guidelines are described in The guidelines manual. |
4.2 Related NICE guidance
Details are correct at the time of publication of the guideline (23 July 2014). Further information is available on the NICE website.
Published
General
-
Patient experience in adult NHS services (2012) NICE guideline CG138.
-
Medicines adherence (2009) NICE guideline CG76.
Condition-specific
-
Lipid modification (2014) NICE guideline CG181.
-
Atrial fibrillation (2014) NICE guideline CG180.
-
Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (2013) NICE technology appraisal guidance 275.
-
Acute kidney injury (2013) NICE guideline 169.
-
Hyperphosphataemia in chronic kidney disease (2013) NICE guideline CG157.
-
Osteoporosis fragility fracture risk (2012) NICE guideline CG146.
-
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism (2012) NICE technology appraisal guidance 261.
-
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (2012) NICE technology appraisal guidance 256.
-
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (2012) NICE technology appraisal guidance 249.
-
Hypertension (2011) NICE guideline CG127.
-
Peritoneal dialysis (2011) NICE guideline CG125.
-
Anaemia management in people with chronic kidney disease (2011) NICE guideline CG114.
-
Chronic heart failure (2010) NICE guideline CG108.
-
Prevention of cardiovascular disease (2010) NICE guideline PH25.
-
Depression in adults with a chronic physical health problem (2009) NICE guideline CG91.
-
Type 2 diabetes (2008) NICE guideline CG87.
-
Febuxostat for the management of hyperuricaemia in people with gout (2008) NICE technology appraisal guidance 164.
-
Cinacalcet hydrochloride for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy (2007) NICE technology appraisal guidance 117.
-
Brief interventions and referral for smoking cessation (2006) NICE guideline PH1.
-
Type 1 diabetes (2004) NICE guideline CG15.
-
Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure (2002) NICE technology appraisal guidance 48.
Under development
NICE is developing the following guidance. Further information is available on the NICE website.
-
Referral for suspected cancer (update). NICE guideline. Publication expected May 2015.
-
Anaemia management in people with chronic kidney disease (update). NICE guideline. Publication expected July 2015.
-
Type 1 diabetes (update). NICE guideline. Publication expected August 2015.
-
Type 2 diabetes (update). NICE guideline. Publication expected August 2015.